Clinical trial · Observational
To Assess and Compare the Performance Two Approach for Sentinel Lymph Node (SNLD) Biopsy for Endometrial Cancer
Endometrium Kanseri Nedeniyle Opere Olacak hastaların Sentinel Lenf Nodu Diseksiyonu değerlendirilirken kullanılan Iki farklı yöntemin kıyaslaması
NCT04514289CI-TRIAL-00046648unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
to assess and compare the performance two approaches for sentinel lymph node ( SLND) biopsy
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
| Indocyanine Green | — | UNRESOLVED | — |
| Sentinel Lymph Node | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Indocyanine green solution | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- assesment SLND with enjection by using ICG
- description
- Patients who have endometrium cancer; undergo sentinel lymph node detection by using fluorescence imaging with an indocyanine green solution. Two different ways used to assess SLND. The first group in which the cervix is injected superficially with 1 mL of ICG ( indocyanine green) at 4 and 8 o'clock quadrans.
- interventionNames
- Drug: Indocyanine green solution
- label
- assesment SLND with hysterescopy by using ICG
- description
- Patients who have endometrium cancer; undergo sentinel lymph node detection by using fluorescence imaging with an indocyanine green solution. Two different ways used to assess SLND. The second one which ICG has injected the uterine cavity during hysteroscopy. Our aim is to assess and compare the performance two approaches for sentinel lymph node ( SLND) biopsy.
- interventionNames
- Drug: Indocyanine green solution
Primary outcomes (1)
- measure
- SLN detecting rate
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * The patient must be willing and able to provide informed consent * The patient is willing and able to comply with the study protocol * The patient has endometrial cancer and is performed SLND * The patient agrees to follow-up examination out to 5-years post-treatment Exclusion Criteria: * The patient is not a candidate for surgery * The patient has metastasis * The patient has known or suspected allergies to iodine, indocyanine green( ICG)
References
Publications (0)
Data not yet available
No reference posted for this study.